Grant to fund ongoing preclinical research for important proof-of-principle non-human studies in preparation for human gene therapy clinical trials
Dr. George Gittes, the lead researcher and Harvard graduate that developed Genprex’s new potentially curative diabetes gene therapy, was featured in a video interview discussing the therapy.
A UPMC Children’s Hospital of Pittsburgh researcher is crediting a new, supportive environment for entrepreneurs at the University of Pittsburgh for making it possible to license a technology that may one day cure diabetes.
Thirty million Americans are living with diabetes and hoping someday to be cured. That day could come sooner than expected, thanks to a team of researchers at UPMC Children’s Hospital of Pittsburgh. original article: UPMC Children’s Hospital Researchers Working On ‘Groundbreaking’ Procedure To Cure Diabetes – CBS Pittsburgh (cbsnews.com)
Genprex signed an exclusive license agreement with the University of Pittsburgh for a diabetes gene therapy that may have the potential to cure Type 1 and Type 2 diabetes, which together currently affect approximately 30.3 million people in the U.S, or 9 percent of the U.S. population.
September 30, 2015Blog Posts
Let’s talk about what is health and how can this article help you. When was the last time you went out for a 30min walk? Allergy allergy-triggered asthma biopsy cone contact lenses depression dna fatty acids laxatives lymph node otitis media retinopathy urinalysis urine vitreous body. Allergy-triggered asthma blood bank blood type carbohydrate carbohydrate counting cardiologist cough […]
Designed and Secured by Barsec